<H1> Global Immunoassay Market to Grow 6â€“7% CAGR with Surge in POCT Demand by 2029 </H1>
<img class="alignnone size-full wp-image-1733" src="http://dailyinvestorhub.com/wp-content/uploads/2025/04/Immunoassay-Market-1.png" alt="" width="748" height="452" />

<strong><em>The </em></strong><a href="https://meditechinsights.com/immunoassay-market/"><strong><em>immunoassay market</em></strong></a><strong><em> is expected to grow at 6-7% CAGRÂ in the next 5 years.</em></strong>Â The aging patient population and high prevalence of chronic and infectious diseases, growing demand for early and accurate diagnostics, advancement in the immunoassay technologies, growing adoption of immunoassay-based Point-of-Care Testing (POCT) and rapid testing, significant investment in R&amp;D for developing advanced immunoassays, and growing demand for high-sensitivity and ultra-sensitive assays to identify diseases at the earliest stages are some of the key factors driving the immunoassay market.

An immunoassay is a bioanalytical test that uses the principles of immunology to detect the presence or concentration of a specific substance in a sample. This assay relies on antibodies, which are proteins generated by the immune system in response to a particular substance or antigen. Each antibody is highly specific and will only bind to its corresponding antigen. Immunoassays are widely used in clinical diagnostics, drug development, therapeutic drug monitoring, and food safety testing.

<strong>ðŸ”— Want deeper insights? Download the sample report:</strong><strong>
</strong><a href="https://meditechinsights.com/immunoassay-market/request-sample/">https://meditechinsights.com/immunoassay-market/request-sample/</a>

<strong>Expanding applications of immunoassays drive market growth</strong>

Immunoassays have diverse applications due to their ability to precisely detect and quantify specific substances across multiple fields. They are essential in disease diagnosis, allowing healthcare providers to identify disease-specific antigens or antibodies in blood or other bodily fluids, which aids in diagnosing and monitoring infections, autoimmune disorders, and cancers. In drug development, immunoassays support the identification and validation of targets for new drugs and assess how potential drugs interact with specific biomarkers. They are also widely used in environmental testing, detecting pollutants, toxins, and other contaminants in water, air, and soil to monitor environmental safety and protect public health. In the food industry, immunoassays detect foodborne pathogens, such as salmonella and E. coli, and identify allergens like gluten, nuts, and dairy proteins, ensuring food safety compliance. Thus, the growing demand for immunoassays in diagnostics, research, and quality control across various sectors is expected to drive market growth in the coming years.

<strong>Advancements in immunoassay technologies propel market growth</strong>

Continuous advancements in immunoassay technology are transforming medical diagnostics, enabling more precise, rapid, and comprehensive testing that supports improved patient outcomes and personalized medicine. New detection techniques, such as enhanced chemiluminescence, advanced fluorescence, and amplified enzyme-linked immunosorbent assays (ELISAs), have significantly pushed detection limits, improving assay sensitivity and accuracy. Multiplex immunoassays have also become invaluable for measuring multiple analytes within a single sample, offering a more holistic view of complex disease states. Additionally, integratingÂ <strong>artificial intelligence</strong>Â and machine learning enables immunoassays to analyze complex datasets with greater efficiency, providing deeper insights and more accurate results. Looking ahead, advancements such as wearable biosensors and point-of-care diagnostic tools promise real-time health monitoring, which is further expected to propel market growth.

<strong>Competitive Landscape Analysis</strong>

The global immunoassay market is marked by the presence of innovative and emerging market players such as<strong><em>Â Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories, Danaher Corporation, bioMerieux,Â Quidel Corporation, BD Biosciences, Sysmex Corporation, GenScript,Â Quanterix, Thermo Fisher Scientific Inc., and Roche Diagnostics,Â </em></strong>among others. Some of the key strategies adopted by market players include product innovations, investing in R&amp;D, strategic partnerships, and collaborations.

<strong>Gain a competitive edge-request a sample report now!
</strong><a href="https://meditechinsights.com/immunoassay-market/request-sample/">https://meditechinsights.com/immunoassay-market/request-sample/</a>

<strong>Market Segmentation</strong>

This report by Medi-Tech Insights provides theÂ size of the global immunoassay market at theÂ regional- and country level from 2022 to 2029. The report further segments the market based on product, technology, application, and end user.
<ul>
 	<li><strong>Market Size &amp; Forecast (2022-2029), By Product, USD Million</strong>
<ul>
 	<li>Reagents &amp; Kits
<ul>
 	<li>ELISA Reagents &amp; Kits</li>
 	<li>CLIA Reagents &amp; Kits</li>
 	<li>IFA Reagents &amp; Kits</li>
 	<li>Rapid Test Reagents &amp; Kits</li>
 	<li>ELISpot Reagents &amp; Kits</li>
 	<li>Western Blot Reagents &amp; Kits</li>
 	<li>Other Reagents &amp; Kits</li>
</ul>
</li>
 	<li>Analyzers
<ul>
 	<li>Open-ended Systems</li>
 	<li>Closed-ended Systems</li>
</ul>
</li>
</ul>
</li>
 	<li><strong>Market Size &amp; Forecast (2022-2029), By Technology, USD Million</strong>
<ul>
 	<li>Enzyme-linked Immunosorbent assay (ELISA)</li>
 	<li>Chemiluminescence Immunoassay (CLIA)</li>
 	<li>Fluorescence Immunoassay (FIA)</li>
 	<li>Rapid Tests</li>
 	<li>ELISpot</li>
 	<li>Western Blotting</li>
 	<li>Other Technologies</li>
</ul>
</li>
 	<li><strong>Market Size &amp; Forecast (2022-2029), By Application, USD Million</strong>
<ul>
 	<li>Infectious Diseases</li>
 	<li>Endocrinology</li>
 	<li>Oncology</li>
 	<li>Cardiology</li>
 	<li>Autoimmune Disorders</li>
 	<li>Allergy Diagnostics</li>
 	<li>Toxicology</li>
 	<li>Newborn Screening</li>
 	<li>Other Applications</li>
</ul>
</li>
 	<li><strong>Market Size &amp; Forecast (2022-2029), By End User, USD Million</strong>
<ul>
 	<li>Hospitals &amp; Clinics</li>
 	<li>Clinical Laboratories</li>
 	<li>Pharmaceuticals &amp; Biotechnology Companies &amp; CROs</li>
 	<li>Blood Banks</li>
 	<li>Research &amp; Academic Laboratories</li>
 	<li>Home Care Settings</li>
</ul>
</li>
 	<li><strong>Market Size &amp; Forecast (2022-2029), By Region, USD Million</strong>
<ul>
 	<li>North America
<ul>
 	<li>US</li>
 	<li>Canada</li>
</ul>
</li>
 	<li>Europe
<ul>
 	<li>UK</li>
 	<li>Germany</li>
 	<li>France</li>
 	<li>Italy</li>
 	<li>Spain</li>
 	<li>Rest of Europe</li>
</ul>
</li>
 	<li>Asia Pacific
<ul>
 	<li>China</li>
 	<li>India</li>
 	<li>Japan</li>
 	<li>Rest of Asia Pacific</li>
</ul>
</li>
 	<li>Latin America</li>
 	<li>Middle East &amp; Africa</li>
</ul>
</li>
</ul>
<strong>About Medi-Tech Insights</strong>

Medi-Tech Insights is a healthcare-focused business research &amp; insights firm. Our clients include Fortune 500 companies, blue-chip investors &amp; hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices &amp; Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis &amp; go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

<strong>Contact:</strong>

Ruta Halde
Associate, Medi-Tech Insights
<u>Â +32 498 86 80 79
</u><a href="mailto:info@meditechinsights.com">info@meditechinsights.com</a><u>Â </u><img class="alignnone size-full wp-image-1731" src="http://dailyinvestorhub.com/wp-content/uploads/2025/04/Immunoassay-Market.png" alt="" width="748" height="452" />
